Tabouret E, Boucard C, Devillier R, Barrie M, Boussen S, Autran D, Chinot O, Bruder N
Department of Neuro-Oncology, AP-HM, Timone, 264, rue Saint Pierre, 13005, Marseille, France.
Aix-Marseille Université, CRO2, UMR911, 13005, Marseille, France.
J Neurooncol. 2016 Mar;127(1):111-7. doi: 10.1007/s11060-015-2015-7. Epub 2015 Nov 25.
The prognosis of oncology patients admitted to the intensive care unit (ICU) is considered poor. Our objective was to analyze the characteristics and predictive factors of death in the ICU and functional outcome following ICU treatment for neuro-oncology patients. A retrospective study was conducted on all patients with primary brain tumor admitted to our institutional ICU for medical indications. Predictive impact on the risk of death in the ICU was analyzed as well as the functional status was evaluated prior and following ICU discharge. Seventy-one patients were admitted to the ICU. ICU admission indications were refractory seizures (41 %) and septic shock (17 %). On admission, 16 % had multi-organ failure. Ventilation was necessary for 41 % and catecholamines for 13 %. Twenty-two percent of patients died in the ICU. By multivariate analysis, predictive factors associated with an increased risk of ICU death were: non-neurological cause of admission [p = 0.045; odds ratio (OR) 5.405], multiple organ failure (p = 0.021; OR 8.027), respiratory failure (p = 0.006; OR 9.615), and hemodynamic failure (p = 0.008; OR 10.111). In contrast, tumor type (p = 0.678) and disease control status (p = 0.380) were not associated with an increased risk of ICU death. Among the 35 evaluable patients, 77 % presented with a stable or improved Karnofsky performance status following ICU hospitalization compared with the ongoing status before discharge. In patients with primary brain tumor admitted to the ICU, predictive factors of death appear to be similar to those described in non-oncology patients. ICU hospitalization is generally not associated with a subsequent decrease in the functional status.
入住重症监护病房(ICU)的肿瘤患者预后被认为较差。我们的目的是分析神经肿瘤患者在ICU的死亡特征及预测因素,以及ICU治疗后的功能转归。对因医疗指征入住我院ICU的所有原发性脑肿瘤患者进行了一项回顾性研究。分析了对ICU死亡风险的预测影响,并在ICU出院前后评估了功能状态。71例患者入住了ICU。入住ICU的指征为难治性癫痫(41%)和感染性休克(17%)。入院时,16%的患者出现多器官功能衰竭。41%的患者需要通气,13%的患者需要使用儿茶酚胺。22%的患者在ICU死亡。多因素分析显示,与ICU死亡风险增加相关的预测因素为:非神经系统疾病入院原因[p = 0.045;比值比(OR)5.405]、多器官功能衰竭(p = 0.021;OR 8.027)、呼吸衰竭(p = 0.006;OR 9.615)和血流动力学衰竭(p = 0.008;OR 10.111)。相比之下,肿瘤类型(p = 0.678)和疾病控制状态(p = 0.380)与ICU死亡风险增加无关。在35例可评估的患者中,与出院前的持续状态相比,77%的患者在ICU住院后卡氏功能状态稳定或改善。在入住ICU的原发性脑肿瘤患者中,死亡的预测因素似乎与非肿瘤患者中描述的相似。ICU住院通常与随后的功能状态下降无关。